Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Paracetamol intravenous - Bristol-Myers Squibb/Mallinckrodt

Drug Profile

Paracetamol intravenous - Bristol-Myers Squibb/Mallinckrodt

Alternative Names: Acelio; acetaminophen IV; Acetavance; IV APAP; Ofirmev; Perfalgan; TRM-1106

Latest Information Update: 02 Jun 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharmatop
  • Developer Bristol-Myers Squibb; Mallinckrodt plc; Terumo
  • Class Acetanilides; Aminophenols; Antipyretics; Non-opioid analgesics; Small molecules
  • Mechanism of Action Prostaglandin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Fever; Pain

Most Recent Events

  • 02 Jun 2017 No recent reports on development identified - Registered for Fever and Pain in Canada (IV)
  • 18 Nov 2016 Mallinckrodt Pharmaceuticals completes a Pharmacokinetics trial in United Kingdom
  • 08 Nov 2016 The US FDA approved a Prior Approval Supplement for acetaminophen injection
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top